StockData
EoCene Ltd. logo

EoCene Ltd. (EOCN) stock

EOCNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 31, 2026Score 5/30
$2.20−0.26 (-10.63%)

Close on Nov 18, 2026Market cap $2.20MP/E –Yield –

EoCene operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

For fiscal 2020 it was -$30.21M.

Annual operating income

PeriodPeriod endValueChange
FY2020Dec 31, 2020-$30.21M–
FY2019Dec 31, 2019-$22.38M–
FY2018Dec 31, 2018-$10.72M–
FY2017Dec 31, 2017-$12.36M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2020Jun 30, 2020-$5.82M–
Q2 FY2019Jun 30, 2019-$4.70M–

More EoCene figures

See a number that looks wrong?